Introduction: Fasting for 24 hours improves functional recovery and reduces
injury due to global ischemia and reperfusion. Since fasting affects catec
holamine kinetics, and norepinephrine (NE) release has been implicated as a
mediator of dysrhythmias and injury with myocardial ischemia, we hypothesi
zed that fasting would limit NE release following ischemia and reperfusion
as a mechanism of its beneficial effects. Methods: Hearts were isolated and
perfused from rats either fed normally or fasted for 24 hours. Following b
aseline perfusion, hearts were subjected to 20 minutes of ischemia followed
by reperfusion. Hemodynamics (developed and end-diastolic pressure) and dy
srhythmias were monitored, and creatine kinase release on reperfusion was m
easured as a marker of cellular injury. NE tissue content was assessed prio
r to ischemia and NE release was measured upon reperfusion with and without
blockade of the uptake(1) carrier using desipramine. Results: The release
of NE was reduced by fasting (0.52 +/- 0.14 vs. 1.47 +/- 0.15 nmol/gdw, p <
0.001) associated with a reduction in dysrhythmias, lower creatine kinase
release, and lower end-diastolic pressure on reperfusion. However, fasting
did not reduce NE tissue stores prior to ischemia. Desipramine also reduced
NE release on reperfusion and limited the frequency of dysrhythmias, but d
id not alter ischemic injury. Conclusions: Fasting limits NE release after
ischemia and reperfusion, an effect not due to lower NE stores. Lower NE re
lease, either by fasting or blockade of the uptake(1) carrier, significantl
y reduces the frequency of dysrhythmias. However, the amount of NE release,
per se, does not alter ischemic injury, suggesting that the infarct limiti
ng effect of fasting is not mediated by lower NE release.